Equipment characterization to mitigate risks during transfers of cell culture manufacturing processes

The production of monoclonal antibodies by mammalian cell culture in bioreactors up to 25,000 L is state of the art technology in the biotech industry. During the lifecycle of a product, several scale up activities and technology transfers are typically executed to enable the supply chain strategy o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cytotechnology (Dordrecht) 2016-08, Vol.68 (4), p.1381-1401
Hauptverfasser: Sieblist, Christian, Jenzsch, Marco, Pohlscheidt, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1401
container_issue 4
container_start_page 1381
container_title Cytotechnology (Dordrecht)
container_volume 68
creator Sieblist, Christian
Jenzsch, Marco
Pohlscheidt, Michael
description The production of monoclonal antibodies by mammalian cell culture in bioreactors up to 25,000 L is state of the art technology in the biotech industry. During the lifecycle of a product, several scale up activities and technology transfers are typically executed to enable the supply chain strategy of a global pharmaceutical company. Given the sensitivity of mammalian cells to physicochemical culture conditions, process and equipment knowledge are critical to avoid impacts on timelines, product quantity and quality. Especially, the fluid dynamics of large scale bioreactors versus small scale models need to be described, and similarity demonstrated, in light of the Quality by Design approach promoted by the FDA . This approach comprises an associated design space which is established during process characterization and validation in bench scale bioreactors. Therefore the establishment of predictive models and simulation tools for major operating conditions of stirred vessels (mixing, mass transfer, and shear force.), based on fundamental engineering principles, have experienced a renaissance in the recent years. This work illustrates the systematic characterization of a large variety of bioreactor designs deployed in a global manufacturing network ranging from small bench scale equipment to large scale production equipment (25,000 L). Several traditional methods to determine power input, mixing, mass transfer and shear force have been used to create a data base and identify differences for various impeller types and configurations in operating ranges typically applied in cell culture processes at manufacturing scale. In addition, extrapolation of different empirical models, e.g. Cooke et al. (Paper presented at the proceedings of the 2nd international conference of bioreactor fluid dynamics, Cranfield, UK, 1988 ), have been assessed for their validity in these operational ranges. Results for selected designs are shown and serve as examples of structured characterization to enable fast and agile process transfers, scale up and troubleshooting.
doi_str_mv 10.1007/s10616-015-9899-0
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4960186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1807276382</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-ad6a5ac57a72f2fa7dec66d82058ae15a0d0511039ddfdbd6810a06b341706803</originalsourceid><addsrcrecordid>eNp1kU1rFTEUhoMo9rb6A9xIwI2b0XMyN18bQUqtQsGNrkNukrlNnZlMk0xBf70zTK0f4CqLPHlO3vMS8gLhDQLItwVBoGgAeaOV1g08Ijvksm1ASvWY7EAzaDQIfUJOS7kBAC2xfUpOmGAtqna_I-Hido7TEMZK3bXN1tWQ4w9bYxppTXSINR5tDTTH8q1QP-c4HmnNdixdyIWmjrrQ99TNfZ1zoIMd526RbNyUkwulhPKMPOlsX8Lz-_OMfP1w8eX8Y3P1-fLT-furxnGQtbFeWG4dl1ayjnVW-uCE8IoBVzYgt-CBI0Krve_8wQuFYEEc2j1KEAraM_Ju807zYQjeLbGy7c2U42Dzd5NsNH_fjPHaHNOd2WsBqMQieH0vyOl2DqWaIZY1oR1DmotBBZJJ0Sq2oK_-QW_SnMclnmEaFeMtw1WIG-VyKiWH7uEzCGYt0WwlmqVEs5Zo1hQv_0zx8OJXawvANqBM655D_j36_9afer-qfQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918253216</pqid></control><display><type>article</type><title>Equipment characterization to mitigate risks during transfers of cell culture manufacturing processes</title><source>Springer Nature - Complete Springer Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>ProQuest Central</source><creator>Sieblist, Christian ; Jenzsch, Marco ; Pohlscheidt, Michael</creator><creatorcontrib>Sieblist, Christian ; Jenzsch, Marco ; Pohlscheidt, Michael</creatorcontrib><description>The production of monoclonal antibodies by mammalian cell culture in bioreactors up to 25,000 L is state of the art technology in the biotech industry. During the lifecycle of a product, several scale up activities and technology transfers are typically executed to enable the supply chain strategy of a global pharmaceutical company. Given the sensitivity of mammalian cells to physicochemical culture conditions, process and equipment knowledge are critical to avoid impacts on timelines, product quantity and quality. Especially, the fluid dynamics of large scale bioreactors versus small scale models need to be described, and similarity demonstrated, in light of the Quality by Design approach promoted by the FDA . This approach comprises an associated design space which is established during process characterization and validation in bench scale bioreactors. Therefore the establishment of predictive models and simulation tools for major operating conditions of stirred vessels (mixing, mass transfer, and shear force.), based on fundamental engineering principles, have experienced a renaissance in the recent years. This work illustrates the systematic characterization of a large variety of bioreactor designs deployed in a global manufacturing network ranging from small bench scale equipment to large scale production equipment (25,000 L). Several traditional methods to determine power input, mixing, mass transfer and shear force have been used to create a data base and identify differences for various impeller types and configurations in operating ranges typically applied in cell culture processes at manufacturing scale. In addition, extrapolation of different empirical models, e.g. Cooke et al. (Paper presented at the proceedings of the 2nd international conference of bioreactor fluid dynamics, Cranfield, UK, 1988 ), have been assessed for their validity in these operational ranges. Results for selected designs are shown and serve as examples of structured characterization to enable fast and agile process transfers, scale up and troubleshooting.</description><identifier>ISSN: 0920-9069</identifier><identifier>EISSN: 1573-0778</identifier><identifier>DOI: 10.1007/s10616-015-9899-0</identifier><identifier>PMID: 26231834</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Biochemistry ; Biomedicine ; Bioreactors ; Biotechnology ; Biotechnology industry ; Carbon dioxide ; Cell culture ; Chemistry ; Chemistry and Materials Science ; Fermentation ; Fluid dynamics ; Friction ; Gases ; Mammalian cells ; Manufacturing ; Mass transfer ; Monoclonal antibodies ; Original ; Original Article ; Oxygen saturation ; Power ; Prediction models ; Product quality</subject><ispartof>Cytotechnology (Dordrecht), 2016-08, Vol.68 (4), p.1381-1401</ispartof><rights>Springer Science+Business Media Dordrecht 2015</rights><rights>Springer Science+Business Media Dordrecht 2015.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-ad6a5ac57a72f2fa7dec66d82058ae15a0d0511039ddfdbd6810a06b341706803</citedby><cites>FETCH-LOGICAL-c507t-ad6a5ac57a72f2fa7dec66d82058ae15a0d0511039ddfdbd6810a06b341706803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960186/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2918253216?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,21367,27901,27902,33721,33722,41464,42533,43781,51294,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26231834$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sieblist, Christian</creatorcontrib><creatorcontrib>Jenzsch, Marco</creatorcontrib><creatorcontrib>Pohlscheidt, Michael</creatorcontrib><title>Equipment characterization to mitigate risks during transfers of cell culture manufacturing processes</title><title>Cytotechnology (Dordrecht)</title><addtitle>Cytotechnology</addtitle><addtitle>Cytotechnology</addtitle><description>The production of monoclonal antibodies by mammalian cell culture in bioreactors up to 25,000 L is state of the art technology in the biotech industry. During the lifecycle of a product, several scale up activities and technology transfers are typically executed to enable the supply chain strategy of a global pharmaceutical company. Given the sensitivity of mammalian cells to physicochemical culture conditions, process and equipment knowledge are critical to avoid impacts on timelines, product quantity and quality. Especially, the fluid dynamics of large scale bioreactors versus small scale models need to be described, and similarity demonstrated, in light of the Quality by Design approach promoted by the FDA . This approach comprises an associated design space which is established during process characterization and validation in bench scale bioreactors. Therefore the establishment of predictive models and simulation tools for major operating conditions of stirred vessels (mixing, mass transfer, and shear force.), based on fundamental engineering principles, have experienced a renaissance in the recent years. This work illustrates the systematic characterization of a large variety of bioreactor designs deployed in a global manufacturing network ranging from small bench scale equipment to large scale production equipment (25,000 L). Several traditional methods to determine power input, mixing, mass transfer and shear force have been used to create a data base and identify differences for various impeller types and configurations in operating ranges typically applied in cell culture processes at manufacturing scale. In addition, extrapolation of different empirical models, e.g. Cooke et al. (Paper presented at the proceedings of the 2nd international conference of bioreactor fluid dynamics, Cranfield, UK, 1988 ), have been assessed for their validity in these operational ranges. Results for selected designs are shown and serve as examples of structured characterization to enable fast and agile process transfers, scale up and troubleshooting.</description><subject>Biochemistry</subject><subject>Biomedicine</subject><subject>Bioreactors</subject><subject>Biotechnology</subject><subject>Biotechnology industry</subject><subject>Carbon dioxide</subject><subject>Cell culture</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Fermentation</subject><subject>Fluid dynamics</subject><subject>Friction</subject><subject>Gases</subject><subject>Mammalian cells</subject><subject>Manufacturing</subject><subject>Mass transfer</subject><subject>Monoclonal antibodies</subject><subject>Original</subject><subject>Original Article</subject><subject>Oxygen saturation</subject><subject>Power</subject><subject>Prediction models</subject><subject>Product quality</subject><issn>0920-9069</issn><issn>1573-0778</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kU1rFTEUhoMo9rb6A9xIwI2b0XMyN18bQUqtQsGNrkNukrlNnZlMk0xBf70zTK0f4CqLPHlO3vMS8gLhDQLItwVBoGgAeaOV1g08Ijvksm1ASvWY7EAzaDQIfUJOS7kBAC2xfUpOmGAtqna_I-Hido7TEMZK3bXN1tWQ4w9bYxppTXSINR5tDTTH8q1QP-c4HmnNdixdyIWmjrrQ99TNfZ1zoIMd526RbNyUkwulhPKMPOlsX8Lz-_OMfP1w8eX8Y3P1-fLT-furxnGQtbFeWG4dl1ayjnVW-uCE8IoBVzYgt-CBI0Krve_8wQuFYEEc2j1KEAraM_Ju807zYQjeLbGy7c2U42Dzd5NsNH_fjPHaHNOd2WsBqMQieH0vyOl2DqWaIZY1oR1DmotBBZJJ0Sq2oK_-QW_SnMclnmEaFeMtw1WIG-VyKiWH7uEzCGYt0WwlmqVEs5Zo1hQv_0zx8OJXawvANqBM655D_j36_9afer-qfQ</recordid><startdate>20160801</startdate><enddate>20160801</enddate><creator>Sieblist, Christian</creator><creator>Jenzsch, Marco</creator><creator>Pohlscheidt, Michael</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160801</creationdate><title>Equipment characterization to mitigate risks during transfers of cell culture manufacturing processes</title><author>Sieblist, Christian ; Jenzsch, Marco ; Pohlscheidt, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-ad6a5ac57a72f2fa7dec66d82058ae15a0d0511039ddfdbd6810a06b341706803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biochemistry</topic><topic>Biomedicine</topic><topic>Bioreactors</topic><topic>Biotechnology</topic><topic>Biotechnology industry</topic><topic>Carbon dioxide</topic><topic>Cell culture</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Fermentation</topic><topic>Fluid dynamics</topic><topic>Friction</topic><topic>Gases</topic><topic>Mammalian cells</topic><topic>Manufacturing</topic><topic>Mass transfer</topic><topic>Monoclonal antibodies</topic><topic>Original</topic><topic>Original Article</topic><topic>Oxygen saturation</topic><topic>Power</topic><topic>Prediction models</topic><topic>Product quality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sieblist, Christian</creatorcontrib><creatorcontrib>Jenzsch, Marco</creatorcontrib><creatorcontrib>Pohlscheidt, Michael</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cytotechnology (Dordrecht)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sieblist, Christian</au><au>Jenzsch, Marco</au><au>Pohlscheidt, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Equipment characterization to mitigate risks during transfers of cell culture manufacturing processes</atitle><jtitle>Cytotechnology (Dordrecht)</jtitle><stitle>Cytotechnology</stitle><addtitle>Cytotechnology</addtitle><date>2016-08-01</date><risdate>2016</risdate><volume>68</volume><issue>4</issue><spage>1381</spage><epage>1401</epage><pages>1381-1401</pages><issn>0920-9069</issn><eissn>1573-0778</eissn><abstract>The production of monoclonal antibodies by mammalian cell culture in bioreactors up to 25,000 L is state of the art technology in the biotech industry. During the lifecycle of a product, several scale up activities and technology transfers are typically executed to enable the supply chain strategy of a global pharmaceutical company. Given the sensitivity of mammalian cells to physicochemical culture conditions, process and equipment knowledge are critical to avoid impacts on timelines, product quantity and quality. Especially, the fluid dynamics of large scale bioreactors versus small scale models need to be described, and similarity demonstrated, in light of the Quality by Design approach promoted by the FDA . This approach comprises an associated design space which is established during process characterization and validation in bench scale bioreactors. Therefore the establishment of predictive models and simulation tools for major operating conditions of stirred vessels (mixing, mass transfer, and shear force.), based on fundamental engineering principles, have experienced a renaissance in the recent years. This work illustrates the systematic characterization of a large variety of bioreactor designs deployed in a global manufacturing network ranging from small bench scale equipment to large scale production equipment (25,000 L). Several traditional methods to determine power input, mixing, mass transfer and shear force have been used to create a data base and identify differences for various impeller types and configurations in operating ranges typically applied in cell culture processes at manufacturing scale. In addition, extrapolation of different empirical models, e.g. Cooke et al. (Paper presented at the proceedings of the 2nd international conference of bioreactor fluid dynamics, Cranfield, UK, 1988 ), have been assessed for their validity in these operational ranges. Results for selected designs are shown and serve as examples of structured characterization to enable fast and agile process transfers, scale up and troubleshooting.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>26231834</pmid><doi>10.1007/s10616-015-9899-0</doi><tpages>21</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0920-9069
ispartof Cytotechnology (Dordrecht), 2016-08, Vol.68 (4), p.1381-1401
issn 0920-9069
1573-0778
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4960186
source Springer Nature - Complete Springer Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; ProQuest Central
subjects Biochemistry
Biomedicine
Bioreactors
Biotechnology
Biotechnology industry
Carbon dioxide
Cell culture
Chemistry
Chemistry and Materials Science
Fermentation
Fluid dynamics
Friction
Gases
Mammalian cells
Manufacturing
Mass transfer
Monoclonal antibodies
Original
Original Article
Oxygen saturation
Power
Prediction models
Product quality
title Equipment characterization to mitigate risks during transfers of cell culture manufacturing processes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T17%3A08%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Equipment%20characterization%20to%20mitigate%20risks%20during%20transfers%20of%20cell%20culture%20manufacturing%20processes&rft.jtitle=Cytotechnology%20(Dordrecht)&rft.au=Sieblist,%20Christian&rft.date=2016-08-01&rft.volume=68&rft.issue=4&rft.spage=1381&rft.epage=1401&rft.pages=1381-1401&rft.issn=0920-9069&rft.eissn=1573-0778&rft_id=info:doi/10.1007/s10616-015-9899-0&rft_dat=%3Cproquest_pubme%3E1807276382%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2918253216&rft_id=info:pmid/26231834&rfr_iscdi=true